Your session is about to expire
← Back to Search
Cohort 3 - lower dose active + SOC treatment vs. SOC alone in lower weight range for Necrotizing Enterocolitis
Study Summary
This trial aims to test the safety and effectiveness of two different doses of ST266 given once a day through an IV to treat patients with Bell's stage IIA or higher NEC. The main goal is
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 2 trial • 151 Patients • NCT02761993Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the trial open to individuals younger than 85 years old?
"Participants in this research must be between 2 and 8 weeks old. Notably, there are a total of 24 trials catering to individuals under 18 years of age and an additional seven for those above the age of 65."
Is the enrollment process currently open for this research study?
"Indeed, the details on clinicaltrials.gov indicate an ongoing search for participants in this study. The trial first appeared online on March 29th, 2024 and saw its latest update on April 1st of the same year. Specifically, the research aims to enroll a total of 36 patients at one designated site."
What is the total number of participants being recruited for this research endeavor?
"Indeed, the details on clinicaltrials.gov indicate that this investigation is actively seeking participants. The trial was initially listed on March 29th, 2024 and most recently revised on April 1st, 2024. A total of 36 individuals are sought from a singular site."
Share this study with friends
Copy Link
Messenger